Bibliotecas PUC-SP - Busca Integrada

Health-Related Quality of Life, Psychosocial Distress and Unmet Needs in Older Patients With Head and Neck Cancer

за авторством Lachlan McDowell, Lachlan McDowell, Danny Rischin, Danny Rischin, Karla Gough, Karla Gough, Christina Henson
Опубліковано в: Frontiers in Oncology (2022-02-01)

Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors

за авторством Lachlan McDowell, Lachlan McDowell, June Corry, June Corry, Jolie Ringash, Danny Rischin, Danny Rischin
Опубліковано в: Frontiers in Oncology (2020-06-01)

Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma

за авторством Annette M. Lim, Sandro Porceddu, Danny Rischin
Опубліковано в: Current Oncology (2025-08-01)

Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma

за авторством Annette M. Lim, Annette M. Lim, Karda Cavanagh, Rodney J. Hicks, Luke McLean, Michelle S. Goh, Angela Webb, Danny Rischin, Danny Rischin
Опубліковано в: Frontiers in Oncology (2021-04-01)

Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma

за авторством Alesha A. Thai, Annette M. Lim, Benjamin J. Solomon, Danny Rischin
Опубліковано в: Cancers (2021-11-01)

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma

за авторством Luke S. McLean, Annette M. Lim, Annette M. Lim, Angela Webb, Angela Webb, Karda Cavanagh, Alesha Thai, Matthew Magarey, Carly Fox, Stephen Kleid, Danny Rischin, Danny Rischin
Опубліковано в: Frontiers in Oncology (2022-01-01)

Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy

за авторством Karda Cavanagh, Luke S. McLean, Annette M. Lim, Anthony Cardin, Sidney M. Levy, Danny Rischin
Опубліковано в: Cancer Imaging (2024-03-01)

Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure

за авторством June Corry, June Corry, June Corry, Alisha Moore, Liz Kenny, Liz Kenny, Chris Wratten, Tsien Fua, Charles Lin, Sandro Porceddu, Chen Liu, Michael Ruemelin, Amy Sharkey, Lachlan McDowell, Dean Wilkinson, Albert Tiong, Danny Rischin, Danny Rischin
Опубліковано в: Frontiers in Oncology (2024-02-01)

FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

за авторством Luke S. McLean, Karda Cavanagh, Rodney J. Hicks, Jason Callahan, Jing Xie, Anthony Cardin, Annette M. Lim, Danny Rischin
Опубліковано в: Cancer Imaging (2021-10-01)

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation

за авторством Yada Kanjanapan, Siddhartha Deb, Richard J. Young, Mathias Bressel, Linda Mileshkin, Danny Rischin, Michael S. Hofman, Kailash Narayan, Shankar Siva
Опубліковано в: Clinical and Translational Radiation Oncology (2017-02-01)

351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and...

за авторством Makoto Tahara, Kevin Harrington, Ezra Cohen, Barbara Burtness, Quynh-Thu Le, Lisa Licitra, Jean-Pascal Machiels, Lilian Siu, Danny Rischin, Jan Vermorken, Natalyn Hawk, Joy Ge, Behzad Bidadi, Ramona Swaby
Опубліковано в: Journal for ImmunoTherapy of Cancer (2020-11-01)

Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma

за авторством Lachlan McDowell, Georgina Casswell, Mathias Bressel, Karla Gough, Allison Drosdowsky, Andrew Coleman, Sudi Shrestha, Ieta D'Costa, Tsien Fua, Albert Tiong, Chen Liu, Sweet Ping Ng, Benjamin Solomon, Danny Rischin
Опубліковано в: Clinical and Translational Radiation Oncology (2020-03-01)

Care plus study: a multi-site implementation of early palliative care in routine practice to improve health outcomes and reduce hospital admissions for people with advanced cancer:...

за авторством Jennifer Philip, Roslyn Le Gautier, Anna Collins, Anna K. Nowak, Brian Le, Gregory B. Crawford, Nicole Rankin, Meinir Krishnasamy, Geoff Mitchell, Sue-Anne McLachlan, Maarten IJzerman, Robyn Hudson, Danny Rischin, Tanara Vieira Sousa, Vijaya Sundararajan
Опубліковано в: BMC Health Services Research (2021-05-01)

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors

за авторством David Turner, Antoine Italiano, Victor Moreno, Steven Hirschfeld, Juan Martin-Liberal, Michele Maio, Todd M Bauer, Christophe Le Tourneau, Danny Rischin, Catherine Ellis, Eric Angevin, Aaron Hansen, Helen Zhou, Ivan Diaz-Padilla, Frans Opdam, Sapna Yadavilli, Marc Ballas
Опубліковано в: Journal for ImmunoTherapy of Cancer (2025-08-01)

Randomized Phase II Study of Duligotuzumab (MEHD7945A) versus Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEGHAN Study)

за авторством Jérôme FAYETTE, Lori Wirth, Cristina Oprean, Anghel Udrea, Antonio Jimeno, Danny Rischin, Christopher Nutting, Paul M. Harari, Tibor Csoszi, Dana Cernea, Paul O’Brien, William D. Hanley, Amy V. Kapp, Maria Anderson, Elicia Penuel, Bruce McCall, Andrea Pirzkall, Jan Baptist Vermorken
Опубліковано в: Frontiers in Oncology (2016-10-01)

547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma

за авторством Andrew Haydon, Celeste Lebbe, Jose Lutzky, Gregory Daniels, Ragini Kudchadkar, Ann Silk, Nikhil Khushalani, Frances Collichio, Jean-Jaques Grob, Samantha Bowyer, Praveen Bommareddy, Andrew Hill, Danny Rischin, Daniel Brungs, Michael Migden, Matthew Fury, Jenny Lee, Muhammad Alamgeer, Dimitrios Colevas, Wanxing Chai-Ho, Piyush Sheladia, Shui He, Claudia Andreu-Vieyra
Опубліковано в: Journal for ImmunoTherapy of Cancer (2021-11-01)

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

за авторством Dirk Schadendorf, Chieh-I Chen, Zhen Chen, Israel Lowy, Elizabeth Stankevich, Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Brett G M Hughes, Anne Lynn S Chang, Emmanuel Okoye, Jocelyn Booth, Siyu Li, Matthew G Fury, Alexander Guminski, Medha Sasane, Alesha A Thai, Suk-Young Yoo, Vera Mastey
Опубліковано в: Journal for ImmunoTherapy of Cancer (2021-08-01)

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

за авторством Dirk Schadendorf, Ralf Gutzmer, Thomas Eigentler, Israel Lowy, Vladimir Jankovic, Elizabeth Stankevich, Anna C Pavlick, Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Brett G M Hughes, Lara A Dunn, Leonel Hernandez-Aya, Anne Lynn S Chang, Badri Modi, Axel Hauschild, Claas Ulrich, Brian Stein, Jessica L Geiger, Murad Alam, Emmanuel Okoye, Melissa Mathias, Jocelyn Booth, Siyu Li, Matthew G Fury, Alexander Guminski
Опубліковано в: Journal for ImmunoTherapy of Cancer (2020-05-01)

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

за авторством Dirk Schadendorf, Thomas K Eigentler, Israel Lowy, Apostolos Papachristos, Samantha Bowyer, Friedegund Meier, Brigitte Dreno, Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Brett G M Hughes, Axel Hauschild, Brian Stein, Emmanuel Okoye, Jocelyn Booth, Matthew G Fury, Alexander Guminski, Sophie Dalac, Frank Seebach, Marie Beylot-Barry, Suk-Young Yoo, Nicole Basset-Séguin, Sabiha Trabelsi Messai, Victoria Casado Echarren, Anne J Paccaly, Jenny-Hoa Nguyen
Опубліковано в: Journal for ImmunoTherapy of Cancer (2024-03-01)